Once the proverbial “ball starts rolling” The Commission will enter into a consultation with all parties concerned in the hopes of obtaining a resolution to the issue at hand. The issue at hand being the removal, restriction, or prevention, of an IVD medical device, that is hurting patients and users while employed in its intended use, from being on the market in the EU. If it has been determined the issue is rooted in a problem with a specific standard or a common technical specification – CTS – (a rare event indeed), the Commission is required to bring the issue to the Committee (Article 6 of the IVDD) within two (2) months. However, if the Commission deems a Member State has unjustly acted, the Commission is required to notify the Member State of their decision to rescind the Member State’s action. Ultimately the manufacturer and/or the Authorized European Representative will be notified of the Commission’s final decision.
Finally, when it has been determined that a non-complying device still has the CE marking of conformity affixed, the Member State is required to pursue an appropriate course of action to ensure the CE mark is removed. The process of CE mark removal is eloquently simple. The notified body will contact an IVD medical device manufacturer’s Chief Jailable Officer (CJO) and politely state, “Take that the CE mark off the offending product now.” Can you say interruption of the supply chain? By the way, regulatory bodies have a way of sharing information. The chances are pretty good that if devices are hurting folks in the EU; MHLW, Health Canada, and of course your friends at the FDA are probably aware of the problem. Ouch!
What IVD device manufacturers need to do
The best device the doctor can possibly offer is that when a Member State has determined your organization’s products are hurting people, you need to act immediately. Dr. D recommends putting a cross-functional-team together that is capable of collecting and analyzing information quickly. In fact, the CJO should be the point person on this team. That being said, the chances are pretty darn good that a recall will be one of the outcomes. Crisis management tools should be employed. Ensure your authorized representative, notified body, the Competent Authorities, and most important the customers are identified as key stakeholders in the process. If possible, it is always preferred to have replacement product available, if the safety and efficacy issue is not rooted in the actual design. If that is not possible, and you may think the doctor is completely bonkers, but the ethical thing to do is point customers in the direction of a competitor to fill the void resulting from a market withdraw. Yes, there is risk pursuing this approach; however, the best interests of the patient and user must always be considered first.
On the flip-side of the argument, there is a possibility the device problem is actually premised on a standard or CTS. If this happens to be the case, this is a golden opportunity to engage the Competent Authorities and provide potential solutions for the standard or CTS issue. Are the Competent Authorities, Commission, or Committee on Standards actually going to listen to the input and constructive feedback provided by the manufacturer? Maybe; however, offering to provide assistance is a nice way to ensure your organization is placed into a positive light after a period of turmoil.
Takeaways
At the end of the day, IVD medical devices are expected to be safe and effective in their intended use. If a Member State determines that a device is causing harm to the patient or user, under Article 8 of the IVDD, they are required to pursue action. These actions can include, (a) market withdraws (recall), (b) prohibited entry, or (c) restricted use. Pick one; however, all three choices are bad. The doctor’s choice is always (d) none of the above.
Until the next installment of DG, when Dr. D provides insight and guidance into complying with Article 9 (Conformity Assessment Procedures) of the In Vitro Diagnostic Medical Device Directive, a.k.a., IVDD – cheers from Dr. D and best wishes for continued professional success.
References: